201 related articles for article (PubMed ID: 33704756)
21. Combining Mass Spectrometry, Surface Acoustic Wave Interaction Analysis, and Cell Viability Assays for Characterization of Shiga Toxin Subtypes of Pathogenic Escherichia coli Bacteria.
Steil D; Pohlentz G; Legros N; Mormann M; Mellmann A; Karch H; Müthing J
Anal Chem; 2018 Aug; 90(15):8989-8997. PubMed ID: 29939014
[TBL] [Abstract][Full Text] [Related]
22. MALDI-2 Mass Spectrometry and Immunohistochemistry Imaging of Gb3Cer, Gb4Cer, and Further Glycosphingolipids in Human Colorectal Cancer Tissue.
Bien T; Perl M; Machmüller AC; Nitsche U; Conrad A; Johannes L; Müthing J; Soltwisch J; Janssen KP; Dreisewerd K
Anal Chem; 2020 May; 92(10):7096-7105. PubMed ID: 32314902
[TBL] [Abstract][Full Text] [Related]
23. PapG subtype-specific binding characteristics of Escherichia coli towards globo-series glycosphingolipids of human kidney and bladder uroepithelial cells.
Legros N; Ptascheck S; Pohlentz G; Karch H; Dobrindt U; Müthing J
Glycobiology; 2019 Oct; 29(11):789-802. PubMed ID: 31361021
[TBL] [Abstract][Full Text] [Related]
24. Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.
Schweppe CH; Hoffmann P; Nofer JR; Pohlentz G; Mormann M; Karch H; Friedrich AW; Müthing J
J Lipid Res; 2010 Aug; 51(8):2282-94. PubMed ID: 20444989
[TBL] [Abstract][Full Text] [Related]
25. Real-time interaction analysis of Shiga toxins and membrane microdomains of primary human brain microvascular endothelial cells.
Detzner J; Steil D; Pohlentz G; Legros N; Humpf HU; Mellmann A; Karch H; Müthing J
Glycobiology; 2020 Feb; 30(3):174-185. PubMed ID: 31691795
[TBL] [Abstract][Full Text] [Related]
26. Colocalization of receptors for Shiga toxins with lipid rafts in primary human renal glomerular endothelial cells and influence of D-PDMP on synthesis and distribution of glycosphingolipid receptors.
Legros N; Pohlentz G; Runde J; Dusny S; Humpf HU; Karch H; Müthing J
Glycobiology; 2017 Oct; 27(10):947-965. PubMed ID: 28535204
[TBL] [Abstract][Full Text] [Related]
27. Differential induction of Shiga toxin in environmental Escherichia coli O145:H28 strains carrying the same genotype as the outbreak strains.
Carter MQ; Pham A; Du WX; He X
Int J Food Microbiol; 2021 Feb; 339():109029. PubMed ID: 33360585
[TBL] [Abstract][Full Text] [Related]
28. Enterohemorrhagic
Detzner J; Pohlentz G; Müthing J
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805890
[TBL] [Abstract][Full Text] [Related]
29. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
30. Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a.
Russo LM; Melton-Celsa AR; O'Brien AD
J Infect Dis; 2016 Apr; 213(8):1271-9. PubMed ID: 26743841
[TBL] [Abstract][Full Text] [Related]
31. Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.
Toval F; Schiller R; Meisen I; Putze J; Kouzel IU; Zhang W; Karch H; Bielaszewska M; Mormann M; Müthing J; Dobrindt U
Infect Immun; 2014 Nov; 82(11):4631-42. PubMed ID: 25156739
[TBL] [Abstract][Full Text] [Related]
32. Characterization of neutral glycosphingolipids from porcine erythrocyte membranes.
Sako F; Gasa S; Makita A
Int J Biochem; 1987; 19(10):923-9. PubMed ID: 3666281
[TBL] [Abstract][Full Text] [Related]
33. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
Pellino CA; Karve SS; Pradhan S; Weiss AA
J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
[TBL] [Abstract][Full Text] [Related]
34. Thin-layer chromatography, overlay technique and mass spectrometry: a versatile triad advancing glycosphingolipidomics.
Meisen I; Mormann M; Müthing J
Biochim Biophys Acta; 2011 Nov; 1811(11):875-96. PubMed ID: 21549856
[TBL] [Abstract][Full Text] [Related]
35. Application of thin-layer chromatography/infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry to structural analysis of bacteria-binding glycosphingolipids selected by affinity detection.
Müsken A; Souady J; Dreisewerd K; Zhang W; Distler U; Peter-Katalinić J; Miller-Podraza H; Karch H; Müthing J
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1032-8. PubMed ID: 20213676
[TBL] [Abstract][Full Text] [Related]
36. Analysis of neutral glycosphingolipids from Trypanosoma brucei.
Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
Vet Parasitol; 2006 Sep; 140(3-4):264-72. PubMed ID: 16806714
[TBL] [Abstract][Full Text] [Related]
37. Shiga toxin subtypes associated with Shiga toxin-producing Escherichia coli strains isolated from red deer, roe deer, chamois, and ibex.
Hofer E; Cernela N; Stephan R
Foodborne Pathog Dis; 2012 Sep; 9(9):792-5. PubMed ID: 22891940
[TBL] [Abstract][Full Text] [Related]
38. Glycosphingolipid expression in acute nonlymphocytic leukemia: common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts.
Cooling LL; Zhang DS; Naides SJ; Koerner TA
Blood; 2003 Jan; 101(2):711-21. PubMed ID: 12393713
[TBL] [Abstract][Full Text] [Related]
39. Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.
Russo LM; Melton-Celsa AR; Smith MJ; O'Brien AD
PLoS One; 2014; 9(3):e93463. PubMed ID: 24671194
[TBL] [Abstract][Full Text] [Related]
40. Overview of the role of Shiga toxins in porcine edema disease pathogenesis.
Casanova NA; Redondo LM; Dailoff GC; Arenas D; Fernández Miyakawa ME
Toxicon; 2018 Jun; 148():149-154. PubMed ID: 29698757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
